11 beta-Hydroxysteroid dehydrogenase activity in Cushing’s syndrome: Explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 12, 1995, Pages 3617-3620

  Stewart, Paul M ^a,b,c,d   Walker, Brian R ^a,b,c,d   Holder, Geoff ^a,b,c,d   O’Halloran, Domhnall ^a,b,c,d   Shackleton, Cedric H L ^a,b,c,d  

^a SELLY OAK HOSPITAL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOTROPIN; HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

CUSHING SYNDROME; ADRENAL CORTEX ADENOMA; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; ECTOPIC CORTICOTROPIN PRODUCTION; ENZYME ACTIVITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LUNG SMALL CELL CANCER; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL;

ACTH SYNDROME, ECTOPIC; CUSHING SYNDROME; FEMALE; HUMAN; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; MALE; MIDDLE AGE; MINERALOCORTICOIDS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

EID: 0028973101     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.12.8530609     Document Type: Article

References (25)

1. Plotz CM, Knowlten AT, Ragan C. 1952 The natural history of Cushing's syndrome. Am J Med. 13:597-614.
2. Howlett TA, Drury PL, Periy L, Doniach I, Rees LH, Besser GM. 1986 Diagnosis and management of ACTH-dependent Cushing's syndrome; comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf). 24:699-713.
3. Odell WD. 1991 Ectopic ACTH syndrome. Endocrinol Metab Clin North Am. 20:371-379.
4. Krakof FLR, Nicolis G, Amsel B. 1975 Pathogenesis of hypertension in Cushing's syndrome. Am J Med. 58:216-220.
5. Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S. 1986 Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab. 62:275-279.
6. Christy NP, Laragh JH. 1961 Pathogenesis of hypokalaemic alkalosis in Cushing's syndrome. N Engl J Med. 265:1083-1088.
7. Schambelan M, Slaton PE, Biglieri EG. 1971 Mineralocorticoid production in hyperandrenocorticism. Am J Med. 51:299-303.
8. Stewart PM. 1994 11β-Hydroxysteroid dehydrogenase. Bailliere Clin Endocrinol Metab. 8:357-378.
9. Monder C, Shackleton CHL, Bradlow HL, et al. 1986 The syndrome of apparent mineralocorticoid excess: its association with 11β-dehydrogenase and 5β-reductase deficiency and some consequences for corticosteroid metabolism. J Clin Endocrinol Metab. 63:550-557.
10. Ulick S, Levine LS, Gunczler P, et al. 1979 A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab. 49:757-764.
11. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW. 1988 Syndrome of apparent mineralocorticoid excess: a defect in the cor-tisol-cortisone shuttle. J Clin Invest. 82:340-349.
12. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CHL, Edwards CRW. 1987 Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet. 2:821-824.
13. Phillipou G. 1982 Investigation of urinary steroid profiles as a diagnostic method in Cushing's syndrome. Clin Endocrinol (Oxf). 16:433-439.
14. Ulick S, Wang JZ, Blumenfeld JD, Pickering TG. 1992 Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 74:963-967.
15. Shackleton CHL. 1993 Mass spectrometry in the diagnosis of ste-roid-related disorders and hypertension research. J Steroid Biochem Mol Biol. 45:127-140.
16. Zumoff B, Fukushima DK, Heilman L. 1974 Intercomparison of four methods for measuring cortisol production. J Clin Endocrinol Metab. 38:169-175.
17. Cost WS. 1963 A mineralocorticoid excess syndrome presumably due to excessive secretion of corticosterone. Lancet. 1:362-363.
18. Edwards CRW, Stewart PM, Burt D, et al. 1988 Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 2:986-989.
19. Funder JW, Pearce FT, Smith R, Smith AI. 1988Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 242:583-585.
20. Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CRW. 1992 Mineralocorticoid excess, and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf). 37:483-492.
21. Walker BR, Edwards CRW. 1991 11β-Hydroxysteroid dehydrogenase and enzyme-mediated receptor protection: life after liquorice?Clin Endocrinol (Oxf)35:281-289.
22. Komel L. 1970 Corticosteroids in human blood. V. Extra-adrenal effect of ACTH upon metabolism of cortisol. Steroidologia. 1:225-245.
23. +-dependent enzyme and differs from the cloned "type I" isoform. J Clin Endocrinol Metab. 79:480-484.
24. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. 1994 Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 105:R11-R17.
25. Rusvai E, Fejes-Toth AN. 1993 A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem. 268: 10717-10720.